The WARD project is thankful for the support of the following collaborators and foundations

Innovationsfonden

Innovation Fund Denmark

Novo Nordisk Fonden

Novo Nordisk Foundation

BetaHealth

Tværspuljen

Danske Regioner

Danish Regions

Digitaliseringsstyrelsen

Agency for Digitisation

Helsefonden

Region Hovedstaden

Capital Region of Denmark

Steno Diabetes Centre Danmark

Copenhagen Centre for Health Technology

Kræftens Bekæmpelse

The Danish Cancer Society

Bispebjerg og Frederiksberg Hospital

DTU Sundhedsteknologi

DTU Health Tech

Rigshospitalet

Radiometer

A.P. Møller Fonden

The A.P. Møller Foundation

Institut for Klinisk Medicin

Department of Clinical Medicine

The WARD founders have created a start-up company, WARD24/7 ApS, with the aim of pursuing the regulatory and commercial activities of the WARD-project (Wireless Assessment of Respiratory and circulatory Distress, a project developing a clinical support system for continuous wireless monitoring of vital signs). WARD24/7 ApS has obtained license agreement for any WARD-project software and patents. One patent has been filed: “Wireless Assessment of Respiratory and circulatory Distress (WARD)– Clinical Support System (CSS) – an automated clinical support system to improve patient safety and outcomes

Please see the regulatory and commercial homepage: WARD247.com